Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "atrial-fibrillation"

40 News Found

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
Medical Device | January 13, 2022

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales


Alembic receives tentative U.S.FDA approval for dronedarone tablets
Drug Approval | January 10, 2022

Alembic receives tentative U.S.FDA approval for dronedarone tablets

Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA


Alembic receives tentative U.S. FDA approval for Dabigatran Etexilate capsules
Drug Approval | November 23, 2021

Alembic receives tentative U.S. FDA approval for Dabigatran Etexilate capsules

Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)


Medtronic first to launch cryoballoon catheter in India
Medical Device | November 10, 2021

Medtronic first to launch cryoballoon catheter in India

Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation


Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
Hospitals | November 05, 2021

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease

The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day


Granules gets ANDA approval for Dofetilide capsules
Drug Approval | October 18, 2021

Granules gets ANDA approval for Dofetilide capsules

The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm


Fortis launches CATH LAB with 3D mapping Carto 7 machine
Hospitals | September 30, 2021

Fortis launches CATH LAB with 3D mapping Carto 7 machine

Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine


Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports


Qardio’s remote patient cardiac monitoring service launched
Medical Device | September 20, 2021

Qardio’s remote patient cardiac monitoring service launched

It is the first-ever fully remote end-to-end Remote Patient Monitoring (RPM) service to include cardiac arrhythmia analysis in a single, intuitive platform


Eagle Pharmaceuticals announces licensing agreement for Landiolol
Biotech | August 10, 2021

Eagle Pharmaceuticals announces licensing agreement for Landiolol

Deal signed with AOP Orphan for US commercial rights